Cowealth Medical China Co.,Ltd. (SHA:603122)
China
· Delayed Price · Currency is CNY 16.68
-0.40 (-2.34%)
At close: Mar 9, 2026
Cowealth Medical China Revenue
Cowealth Medical China had revenue of 181.20M CNY in the quarter ending September 30, 2025, a decrease of -21.27%. This brings the company's revenue in the last twelve months to 777.03M, down -19.93% year-over-year. In the year 2024, Cowealth Medical China had annual revenue of 939.14M, down -14.05%.
Revenue (ttm)
777.03M
Revenue Growth
-19.93%
P/S Ratio
8.54
Revenue / Employee
3.83M
Employees
203
Market Cap
6.64B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.21B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Amoy Diagnostics | 1.13B |
| Shanghai Runda Medical Technology | 7.40B |
| SMO ClinPlus CO.,LTD. | 819.09M |
| Thalys Medical Technology Group | 1.25B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Berry Genomics Co.,Ltd | 941.16M |